Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Lemborexant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,494Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Dayvigo

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Dayvigo

    Lemborexant

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Dayvigo

    Japan
    arrow
    BioAsia
    Not Confirmed

    Eisai

    Lemborexant

    Main Therapeutic Indication : Sleep

    Currency : USD

    2021 Revenue in Millions : 80

    2020 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Dayvigo

    Lemborexant

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Dayvigo

    Japan
    arrow
    BioAsia
    Not Confirmed

    Eisai

    Lemborexant

    Main Therapeutic Indication : Sleep

    Currency : USD

    2022 Revenue in Millions : 207

    2021 Revenue in Millions : 80

    Growth (%) : 157

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Dayvigo

    Lemborexant

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Dayvigo

    Japan
    arrow
    BioAsia
    Not Confirmed

    Eisai

    Lemborexant

    Main Therapeutic Indication : Sleep

    Currency : USD

    2023 Revenue in Millions : 262

    2022 Revenue in Millions : 207

    Growth (%) : 42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Dayvigo

    Lemborexant

    arrow
    BioAsia
    Not Confirmed

    Brand Name : Dayvigo

    Japan
    arrow
    BioAsia
    Not Confirmed

    Eisai

    Lemborexant

    Main Therapeutic Indication : Sleep

    Currency : USD

    2024 Revenue in Millions : 336

    2023 Revenue in Millions : 294

    Growth (%) : 14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.